BRENTUXIMAB‐VEDOTIN AND BENDAMUSTINE IS A FEASIBLE AND EFFECTIVE DRUG COMBINATION AS FIRST‐LINE TREATMENT OF HODGKIN LYMPHOMA IN THE ELDERLY (HALO TRIAL). (12th June 2019) - Gallamini, A.; Schiano de Colella, J.; Viotti, J.; Bijou, F.; Rambaldi, A.; Perrot, A.; Patti, C.; Gastaud, L.; Sorasio, R.; Debaigt, C.; Schiappa, R.; Chamorey, E.; et al.